Omeros Corp (LTS:0KBU)
$ 10 -1.92 (-15.24%) Market Cap: 579.50 Mil Enterprise Value: 665.81 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 45/100

Omeros Corp Regulatory Update Call Transcript

Oct 18, 2021 / 12:30PM GMT
Release Date Price: $5.67 (-26.66%)
Operator

Good morning, and welcome to today's call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be available on the company's website for 1 week from today.

I'll turn over the call to Jennifer Williams, Investor Relations for Omeros.

Jennifer Williams

Good morning, and thank you for joining the call today to discuss the Complete Response Letter received from Food and Drug Administration on Friday, October 15, after market close.

I'd like to remind you that today's call will include forward-looking statements, including statements regarding our ability to resolve the matters set forth in the Complete Response Letter and obtain regulatory approval for narsoplimab, plans regarding future actions and communications with FDA and statements regarding the sufficiency of our capital resources and the availability of funding alternatives. These statements are based on management's beliefs and expectations as of today only and are subject to change. All forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot